Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk IndividualsRelease Date:Quality Improvement Vaccines Japan Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious DiseasesRelease Date:Education Vaccines Japan Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical CancerRelease Date:Education Oncology USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Research Vaccines Italy Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOSRelease Date:Research Oncology USA Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin AmericaRelease Date:Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn OutcomesRelease Date:Quality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement ProjectRelease Date:Partner: American Academy of Family PhysiciansQuality Improvement Internal Medicine USA Title Grant Type Focus Area Country Application Due Date Collaborative Community Oncology Support for Therapy Management in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology Italy, Japan, Spain, United Kingdom Emerging Data and Unmet Needs in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)Release Date:Education Oncology All New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Education in the Era of Emerging Hemophilia Therapy (Round 2)Release Date:Education Rare Disease USA Improving Actionable Biomarker Testing Through Technology-Enabled SolutionsRelease Date:Partner: Conquer Cancer, The ASCO FoundationQuality Improvement Oncology USA USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Special ConsiderationsRelease Date:Education Inflammation & Immunology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Unmet Need and Emerging Data in Muscle Invasive Bladder Cancer (MIBC)Education Oncology USA Bridging the Inflammatory Dermatosis Care Divide with TeledermatologyRelease Date:Partner: The George Washington UniversityQuality Improvement Inflammation & Immunology USA Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research CollaborationRelease Date:Call for Collaborator(s) Vaccines France, Germany COLLABORATE Grant Program: Supporting Ageing Adults Living with Rare DiseasesEducation Rare Disease All Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Inflammatory Bowel Disease (IBD) Fellowship- United StatesRelease Date:Fellowship Inflammation & Immunology USA Improving quality of care for patients with Relapsed/Refractory Multiple Myeloma (RRMM) treated with BCMA BsAbsRelease Date:Quality Improvement Oncology Italy 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Research on Long-Acting Growth HormoneRelease Date:Research Rare Disease All Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All